NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Clinical trials for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to stop bladder cancer from coming back
Disease control Recruiting nowThis phase II trial is testing a combination of two drugs—disitamab vedotin given through a vein and mitomycin C placed directly into the bladder—in 30 people with a specific type of non-muscle-invasive bladder cancer that has a protein called HER2. The goal is to see if this tre…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: PHASE2 • Sponsor: Shanxi Province Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Bladder cancer patients may avoid surgery with new drug combo
Disease control Recruiting nowThis phase 2 trial is testing whether two chemotherapy drugs, gemcitabine and docetaxel, given directly into the bladder can treat high-risk bladder cancer that did not respond to standard BCG therapy. About 174 adults will receive weekly treatments for 6 weeks, then monthly for …
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: PHASE2 • Sponsor: Michael A. O'Donnell • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New RNA drug takes aim at tough bladder cancer
Disease control Recruiting nowThis early-stage trial is testing a new drug called RAG-01 in 72 people with a type of bladder cancer that has not responded to standard therapy. The drug uses a small RNA molecule to try to control the cancer. The main goals are to check safety and find the right dose, while als…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: PHASE1 • Sponsor: Ractigen Therapeutics. • Aim: Disease control
Last updated Jun 26, 2026 15:24 UTC
-
Pee test could replace some painful bladder checks for cancer patients
Diagnosis Recruiting nowThis study is testing whether a simple urine test that looks for tumor DNA can help some bladder cancer patients safely have fewer cystoscopy exams. Cystoscopy involves inserting a camera into the bladder and can be uncomfortable. The trial will enroll 56 high-risk patients who h…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: NA • Sponsor: Lahey Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Bladder cancer study aims to end treatment guesswork
Knowledge-focused Recruiting nowThis study looks at two common treatments for a type of bladder cancer that keeps coming back: treatments that keep the bladder (like medicine placed directly into the bladder) versus surgery to remove the bladder. The goal is to see which option is better for patients' wallets, …
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Bladder cancer Patients' sexual health needs finally addressed in new study
Knowledge-focused Recruiting nowThis study aims to understand the sexual health challenges faced by bladder cancer patients and develop a support program tailored to their needs. Researchers will interview 30 patients to learn about their experiences and preferences for professional help. The goal is to create …
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC